ML Anthology

Using the GEMS System for Cancer Diagnosis and Biomarker Discovery from Microarray Gene Expression Data

Alexander R. Statnikov, Ioannis Tsamardinos, Constantin F. Aliferis
AAAI 2005 pp. 1710-1711
doi:10.1093/annonc/mdp345 /aaai/2005/statnikov2005aaai-using/

Abstract

This phase I-II study demonstrated that postoperative chemoradiotherapy with weekly cisplatin and daily capecitabine is feasible in gastric cancer at the defined dose level. This schedule is currently being tested as the experimental arm in a phase III multicenter study (CRITICS: chemoradiotherapy after induction chemotherapy in cancer of the stomach; Clinicaltrials.gov NCT 00407186).

PDF AAAI Semantic Scholar

Cite

Text

Statnikov et al. "Using the GEMS System for Cancer Diagnosis and Biomarker Discovery from Microarray Gene Expression Data." AAAI Conference on Artificial Intelligence, 2005. doi:10.1093/annonc/mdp345

Markdown

[Statnikov et al. "Using the GEMS System for Cancer Diagnosis and Biomarker Discovery from Microarray Gene Expression Data." AAAI Conference on Artificial Intelligence, 2005.](https://mlanthology.org/aaai/2005/statnikov2005aaai-using/) doi:10.1093/annonc/mdp345

BibTeX

@inproceedings{statnikov2005aaai-using,
  title     = {{Using the GEMS System for Cancer Diagnosis and Biomarker Discovery from Microarray Gene Expression Data}},
  author    = {Statnikov, Alexander R. and Tsamardinos, Ioannis and Aliferis, Constantin F.},
  booktitle = {AAAI Conference on Artificial Intelligence},
  year      = {2005},
  pages     = {1710-1711},
  doi       = {10.1093/annonc/mdp345},
  url       = {https://mlanthology.org/aaai/2005/statnikov2005aaai-using/}
}